These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 16087200)

  • 1. Multiple drug resistance, antimutagenesis and anticarcinogenesis.
    Ferguson LR; De Flora S
    Mutat Res; 2005 Dec; 591(1-2):24-33. PubMed ID: 16087200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug resistance in cancer: its mechanism and its modulation.
    Pauwels EK; Erba P; Mariani G; Gomes CM
    Drug News Perspect; 2007; 20(6):371-7. PubMed ID: 17925891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of jatrophane derivatives on the reversion of MDR1- and MRP-mediated multidrug resistance in the MDA-MB-231 (HTB-26) cell line.
    Ferreira MJ; Gyémánt N; Madureira AM; Tanaka M; Koós K; Didziapetris R; Molnár J
    Anticancer Res; 2005; 25(6B):4173-8. PubMed ID: 16309213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimutagens, anticarcinogens, and effective worldwide cancer prevention.
    Weisburger JH
    J Environ Pathol Toxicol Oncol; 1999; 18(2):85-93. PubMed ID: 15281219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimutagenesis and anticancer effects.
    Bronzetti G; Della Croce C; Aretini P; Fiorio R
    J Environ Pathol Toxicol Oncol; 1996; 15(2-4):59-64. PubMed ID: 9216786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 4th International Conference on Mechanisms of Antimutagenesis and Anticarcinogenesis: a summary.
    Liviero L; von Borstel RC
    Mutat Res; 1996 Feb; 350(1):287-93. PubMed ID: 8657193
    [No Abstract]   [Full Text] [Related]  

  • 7. New approaches to antimutagenesis.
    Heddle JA; Moody J; Thompson LU; Torous DK; Trentin G
    J Environ Pathol Toxicol Oncol; 1999; 18(2):95-101. PubMed ID: 15281220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Janus carcinogens and mutagens.
    von Borstel RC; Higgins JA
    Mutat Res; 1998 Jun; 402(1-2):321-9. PubMed ID: 9675327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective role of glutathione, thiols, and analogues in mutagenesis and carcinogenesis.
    Jernström B; Morgenstern R; Moldéus P
    Basic Life Sci; 1993; 61():137-47. PubMed ID: 8304926
    [No Abstract]   [Full Text] [Related]  

  • 10. Third International Conference on Mechanisms of Antimutagenesis and Anticarcinogenesis.
    De Flora S; Bronzetti G; Weisburger JH
    Cancer Epidemiol Biomarkers Prev; 1991; 1(1):95-9. PubMed ID: 1688263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The modifications of mutagenesis and anticarcinogenesis].
    Khudoleĭ VV
    Vestn Ross Akad Med Nauk; 1993; (1):34-41. PubMed ID: 7682121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimutagenesis/anticarcinogenesis 2001: screening, methods and biomarkers.
    Lohman PH; Gentile JM; Gentile G; Ferguson LR
    Mutat Res; 2001 Sep; 496(1-2):1-4. PubMed ID: 11551474
    [No Abstract]   [Full Text] [Related]  

  • 13. The 4th International Conference on Mechanisms of Antimutagenesis and Anticarcinogenesis. Banff, Canada, 4-9 September 1994.
    Mutat Res; 1996 Feb; 350(1):1-294. PubMed ID: 8657171
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antimutagens and anticarcinogenic agents, identification and mechanisms of action of food xenobiotics].
    el Hamss R; Idaomar M
    Therapie; 2002; 57(6):512-7. PubMed ID: 12666257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antimutagenesis as organism defense system against damaging factors of endogenous and exogenous origin].
    Dvornyk AS; Pererva TP; Kunakh VA
    Tsitol Genet; 2004; 38(5):62-71. PubMed ID: 15771091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-dependent mutagenesis and cancer: a new role for antimutagenesis in cancer prevention?
    MacPhee DG
    Mutat Res; 1998 Jun; 402(1-2):29-39. PubMed ID: 9675238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular perspective: the multidrug transporter.
    Goodsell DS
    Oncologist; 1999; 4(5):428-9. PubMed ID: 10551560
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings of the International Symposium on Antimutagenesis and Anticarcinogenesis. April 25-26, 2002, Valhalla, New York, USA.
    Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S1-108. PubMed ID: 12725235
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent developments in antimutagenesis and anticarcinogenesis.
    Levin M
    Drugs Today (Barc); 2002 Jul; 38(7):495-9. PubMed ID: 12582466
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of antimutagenesis and anticarcinogenesis: role in primary prevention.
    De Flora S; Izzotti A; Bennicelli C
    Basic Life Sci; 1993; 61():1-16. PubMed ID: 8304921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.